
Kyros Therapeutics (India) Limited
Pharmaceutical company manufacturing and distributing various drugs and medicines.
Pharmaceutical company manufacturing and distributing various drugs and medicines.
Kyros Therapeutics (India) Limited (KTIL) is a Public Limited Indian Non-Government Company incorporated in India on 30 March 2005 and has a history of 20 years and one month. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.65 M.
The company currently has active open charges totaling ₹0.79 M.
Pankaj Vyas, Debendranath Sarangi, and Venkateswara Tattugolla serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U24239TG2005PLC045761
045761
Public Limited Indian Non-Government Company
30 Mar 2005
30 Sep 2011
31 Mar 2011
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pankaj Vyas ![]() | Additional Director | 13-Jul-2011 | Current |
Debendranath Sarangi ![]() | Additional Director | 04-Aug-2011 | Current |
Venkateswara Tattugolla ![]() | Additional Director | 05-May-2015 | Current |
Enhance accessibility to Kyros Therapeutics (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Kyros Therapeutics (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
₹0.79 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
21 Jan 2013 | The Karur Vysya Bank Limited | ₹0.27 M | Open |
30 Dec 2011 | The Karur Vysya Bank Limited | ₹0.53 M | Open |
Unlock and access historical data on people associated with Kyros Therapeutics (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kyros Therapeutics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kyros Therapeutics (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Venkateswara Rao Tattugolla was appointed as a Additional Director was appointed as a Additional Director on 05 May 2015 & has been associated with this company since 10 years 6 days .
A charge with The Karur Vysya Bank Limited amounted to Rs. 0.27 M with Charge ID 10406505 was registered on 21 Jan 2013.
A charge with The Karur Vysya Bank Limited amounted to Rs. 0.53 M with Charge ID 10331413 was registered on 30 Dec 2011.
Kyros Therapeutics (India) Limited last Annual general meeting of members was held on 30 Sep 2011 as per latest MCA records.
Debendranath Sarangi was appointed as a Additional Director was appointed as a Additional Director on 04 Aug 2011 & has been associated with this company since 13 years 9 months .
Pankaj Vyas was appointed as a Additional Director was appointed as a Additional Director on 13 Jul 2011 & has been associated with this company since 13 years 9 months .
Kyros Therapeutics (India) Limited was incorporated on 30 Mar 2005.
The authorized share capital of Kyros Therapeutics (India) Limited is ₹ 2.00 M and paid-up capital is ₹ 1.65 M.
Currently 3 directors are associated with Kyros Therapeutics (India) Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Kyros Therapeutics (India) Limited is 5-5-35/304/1/A Ist Floor Mythri Nagar Kukatpally, India, Hyderabad, Telangana, 500072.
The corporate identification number (CIN) of Kyros Therapeutics (India) Limited is U24239TG2005PLC045761 and the company number is 045761 as per Ministry of Corporate Affairs (MCA).
As per the financial statements for fiscal Year 0, The total open charges for Kyros Therapeutics (India) Limited amount to ₹ 0.79 M.
The most recent Balance Sheet for Kyros Therapeutics (India) Limited was filed with the ROC on 31 Mar 2011.
Search company & director profiles for free and gain access to critical business data.
GR
VV
SS
SG
JV